Results 31 to 40 of about 298,746 (351)

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

Annals of the Rheumatic Diseases, 2019
Background Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which ...
B. Hellmich, A. Águeda, S. Monti, F. Buttgereit, H. de Boysson, E. Brouwer, R. Cassie, M. Cid, B. Dasgupta, C. Dejaco, G. Hatemi, Nicole Hollinger, A. Mahr, S. Mollan, C. Mukhtyar, C. Ponte, C. Salvarani, Rajappa Sivakumar, X. Tian, G. Tómasson, C. Turesson, W. Schmidt, P. Villiger, R. Watts, Christopher N. J. Young, R. Luqmani   +25 more
semanticscholar   +1 more source

COVID-19-associated vasculitis and vasculopathy

Journal of Thrombosis and Thrombolysis, 2020
The COVID-19 pandemic now totaling 13,000,000 cases and over 571,000 deaths has continued to teach the medical, scientific and lay communities about viral infectious disease in the modern era.
R. Becker
semanticscholar   +1 more source

Pathogenesis of IgA Vasculitis: An Up-To-Date Review

Frontiers in Immunology, 2021
Immunoglobin A (IgA) vasculitis (IgAV), formerly called the Henoch-Schönlein purpura (HSP), is a small vessel vasculitis, characterized by IgA1-dominant immune deposition at diseased vessel walls.
Yan Song, Xiaohan Huang, Gui-zhen Yu, J. Qiao, Jun Cheng, Jianyong Wu, Jianghua Chen   +6 more
semanticscholar   +1 more source

Vasculitis associated with VEXAS syndrome: A literature review

Frontiers in Medicine, 2022
Vasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Vasculitis is classified according to the size (large, medium, or small) of the blood vessels.
R. Watanabe, Manami Kiji, M. Hashimoto
semanticscholar   +1 more source

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Trials, 2022
Background Belimumab, an anti-B-cell activating factor antibody, is approved for the treatment of auto-antibody positive systemic lupus erythematosus with a high degree of disease activity.
Mieke van Schaik, Eline J. Arends, Darius Soonawala, Ellen van Ommen, Karina de Leeuw, Maarten Limper, Pieter van Paassen, Tom W. J. Huizinga, René E. M. Toes, Cees van Kooten, Joris I. Rotmans, Ton J. Rabelink, Y. K. Onno Teng   +12 more
doaj   +1 more source

Audio-vestibular symptoms in systemic autoimmune diseases [PDF]

, 2018
Immune-mediated inner ear disease can be primary, when the autoimmune response is against the inner ear, or secondary. The latter is characterized by the involvement of the ear in the presence of systemic autoimmune conditions. Sensorineural hearing loss
Adelchi, Croce, D'AGUANNO, VITTORIO, DE VINCENTIIS, Marco, DE VIRGILIO, ARMANDO, DI STADIO, Arianna, GRECO, Antonio, LONGO, Lucia, RALLI, MASSIMO   +7 more
core   +1 more source

Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis:results from a longitudinal, matched-cohort data linkage study [PDF]

, 2020
Objectives: Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV ...
Amft, Nicole, Basu, Neil, Black, Corri, Dhaun, Neeraj, Erwig, Lars, Harvie, John, Kumar, Vinod, Marks, Angharad, McGeoch, Lucy, McLaren, John, Sarica, Shifa H., Sznajd, Jan   +11 more
core   +6 more sources

A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments

Journal of Clinical Medicine, 2022
Retinal vasculitis is characterized by inflammatory involvement of retinal arterioles, venules and/or capillaries and can be associated with a myriad of systemic and ophthalmic diseases.
A. Agarwal, Anne Rübsam, Lynn S Zur Bonsen, F. Pichi, P. Neri, U. Pleyer   +5 more
semanticscholar   +1 more source

New Aspects of Thromboangiitis obliterans (von Winiwarter-Buerger's Disease) [PDF]

, 1984
The existence of thromboangiitis obliterans as a clinical entity has been a matter of debate for many years. In contrast to other immunovasculitides there is no organ involvement while peripheral vessels are affected.
Berlit, Peter, Kessler, C., Krause, Klaus-Henning, Reuther, R.   +3 more
core   +1 more source

A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus

Clinical Proteomics, 2017
Subcellular microvesicles (MVs) have attracted increasing interest during the past decades. While initially considered as inert cellular debris, several important roles for MVs in physiological homeostasis, cancer, cardiovascular, and autoimmune diseases
Christoffer T. Nielsen, Ole Østergaard, Niclas S. Rasmussen, Søren Jacobsen, Niels H. H. Heegaard   +4 more
doaj   +1 more source